SK121293A3 - Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder - Google Patents

Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder Download PDF

Info

Publication number
SK121293A3
SK121293A3 SK1212-93A SK121293A SK121293A3 SK 121293 A3 SK121293 A3 SK 121293A3 SK 121293 A SK121293 A SK 121293A SK 121293 A3 SK121293 A3 SK 121293A3
Authority
SK
Slovakia
Prior art keywords
magnesium
aluminum
bismuth
carbonate
oral pharmaceutical
Prior art date
Application number
SK1212-93A
Other languages
English (en)
Slovak (sk)
Inventor
James G Upson
Carmelita M Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK121293A3 publication Critical patent/SK121293A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK1212-93A 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder SK121293A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04
PCT/US1992/001981 WO1992017164A1 (en) 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress

Publications (1)

Publication Number Publication Date
SK121293A3 true SK121293A3 (en) 1994-07-06

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1212-93A SK121293A3 (en) 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder

Country Status (16)

Country Link
EP (1) EP0578768B1 (de)
JP (1) JPH06506682A (de)
KR (1) KR100238565B1 (de)
AT (1) ATE128351T1 (de)
AU (1) AU665349B2 (de)
BR (1) BR9205827A (de)
CA (1) CA2106215C (de)
CZ (1) CZ282105B6 (de)
DE (1) DE69205158T2 (de)
DK (1) DK0578768T3 (de)
ES (1) ES2077417T3 (de)
GR (1) GR3017580T3 (de)
HU (1) HU213203B (de)
RU (1) RU2126249C1 (de)
SK (1) SK121293A3 (de)
WO (1) WO1992017164A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2146637C (en) * 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
EP0695175A1 (de) * 1993-04-30 1996-02-07 The Procter & Gamble Company Überzogene pharmazeutische zusammensetzungen
DK0698393T3 (da) * 1993-05-19 2002-08-05 Hisamitsu Pharmaceutical Co 3-/-menthoxypropan-1,2-diol som solubiliseringsmiddel og præparat til udvortes brug, der indeholder samme
WO1995005173A1 (en) * 1993-08-17 1995-02-23 Applied Analytical Industries, Inc. Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
WO1995011671A1 (en) * 1993-10-28 1995-05-04 The Procter & Gamble Company Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
BR9507199A (pt) * 1994-03-24 1997-09-09 Procter & Gamble Cellulose Formas de dose sólidas contendo bismuto
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CO4410201A1 (es) * 1994-07-20 1997-01-09 Colgate Palmolive Co Metodos y composiciones farmaceuticas para el tratamiento de transtornos gastricos
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル

Also Published As

Publication number Publication date
EP0578768A1 (de) 1994-01-19
ATE128351T1 (de) 1995-10-15
ES2077417T3 (es) 1995-11-16
WO1992017164A1 (en) 1992-10-15
EP0578768B1 (de) 1995-09-27
AU665349B2 (en) 1996-01-04
AU1761492A (en) 1992-11-02
RU2126249C1 (ru) 1999-02-20
CZ226093A3 (en) 1994-04-13
JPH06506682A (ja) 1994-07-28
CZ282105B6 (cs) 1997-05-14
KR100238565B1 (ko) 2000-02-01
BR9205827A (pt) 1994-06-28
DK0578768T3 (da) 1996-02-05
CA2106215A1 (en) 1992-10-05
HU9302970D0 (en) 1994-01-28
GR3017580T3 (en) 1995-12-31
DE69205158D1 (de) 1995-11-02
HUT65881A (en) 1994-07-28
HU213203B (en) 1997-03-28
DE69205158T2 (de) 1996-04-18
CA2106215C (en) 1997-05-27

Similar Documents

Publication Publication Date Title
US5244670A (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
US5629013A (en) Chewable calcium carbonate antacid tablet compositions
EP1077726B1 (de) Unterdrückung von unerwünschtem geschmack in oralen zusammenstellungen
US5989588A (en) Methods and compositions for preventing and treating heartburn
EP1807068B1 (de) Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption
SK121293A3 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder
EP0578732B1 (de) Kaubare antacida
JPH0948728A (ja) 解熱鎮痛剤
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
US5762962A (en) Antacid pharmaceutical composition
KR20070034576A (ko) 록소프로펜을 함유하는 경구 투여용 조성물
JPH0656677A (ja) 制酸剤組成物
CA2184361C (en) Solid dose forms containing bismuth
US4446132A (en) Nontoxic aspirin composition
EP0777470A1 (de) VERWENDUNG VON VERSTÄRKERN DER PARAZELLULÄREN ABSORPTION, WIE GLUKOSE, ZUR ERHÖHUNG DER ABSORPTION VON HISTAMIN H2-ANTAGONISTENn
ES2274550T3 (es) Procedimientos y composiciones para prevenir y tratar ardor de estomago.
WO1998024455A1 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
WO1999010000A1 (en) Combined preparations for treating upper gastrointestinal tract distress
WO2010067151A1 (en) Quick disintegrating taste masked composition
JP2021070685A (ja) 固形製剤
MX2007007146A (es) Composicion antiacida y refrescante del aliento.
MXPA99001598A (en) Inhibiting undesirable taste in oral compositions
CZ76996A3 (en) Pharmaceutical composition
NZ243613A (en) Tablet comprising praziquantel, pyrantel pamoate and oxantel pamoate in synergistic proportions for treatment of nematode infestations